Isa Goksu was interviewed by Financial IT and talked about the value of AI in the fintech industry.

Read the original content in Financial IT. 

Juan Jose Lopez Murphy wrote an article about Chat GPT and the arrival of AI in people's lives. 

Read the original content in TI Inside. 

Patricia Pomies shared her opinion about how Globant is a company that creates equal opportunities for its globers within its corporate culture.

Read the original content in Forbes. 

Chikku George wrote an article about the new bet that fashion brands are making on NFTS and the luxury brands that are developing their strategies based on this technology.

Read the original content in Community by Nasscom. 

Nicolás Ávila had a conversation with the Digital Disrupted podcast about the evolving role of the CTO and what challenges businesses are facing in relation to legacy technology. 

Listen the original content in Digital Disrupted Podcast.

Juan José López Murphy spoke about how AI continues to be a concern in the role of women in society today. 

Read the original content in Finextra.

Patricia Pomies in an interview on how to help women empower their talent and overcome the difficulties of the current system in the technology industries. 

Read the original content in TN. 

Santiago Fontanarrosa in interview with Nearshore Americas (US) introduced how Globant is working to create sustainable business model solutions for organizations that want to get involved in these green practices. 

Read the original content in Nearshore Americas. 

Matias Rodriguez in the Into The Metaverse Podcast talked about his leadership at head of the Metaverse Studio in Globant and how he helps organizations to create and operate in new virtual spaces. 

Read the original content in Into Meta Media. 

This partnership will help reduce the time and costs of observational and clinical studies, and de-risk research and development (R&D) investment decisions, through artificial intelligence and machine learning

Birmingham - January 25, 2023 - Globant, a digitally native company focused on reinventing businesses through innovative technology solutions, and Dexter, a provider of a software platform created by researchers and clinicians at the University of Birmingham, announced today a partnership to deliver real-world data (RWD) and real-world evidence (RWE) to the healthcare and life sciences industry through the use of artificial intelligence and machine learning technologies. 

According to RBC Capital Markets, approximately 30% of the world's data volume today is generated by the healthcare industry. This data helps to unlock value for patients, providers, payers, and life sciences organizations. The Dexter research platform, which is based on software developed at the University of Birmingham, enables the use of RWE in epidemiology studies, drug safety and effectiveness analyses, and optimization of clinical trials. These capabilities help reduce the time and cost of observational and clinical studies, and de-risk research and development (R&D) investment decisions. 

“Ultimately, RWE facilitates improvements to patient outcomes by enabling a 360-degree-view across the entire patient journey, the prediction of risks and disease progression, and better safety monitoring over time,” said Agustin Lamas, Global Managing Director of Healthcare & Life Sciences at Globant. “For providers and payers, RWE can be a source of insights into the real-world performance of treatments, thus enabling value-based care models and support for clinical decision-making. For drug makers, RWE can bridge patient data between pre- and post-market contexts.” 

With Globant’s mastery in data science, artificial intelligence (AI), and machine learning (ML), its expertise in data governance and data management, and its competencies in building scalable data platforms, integrating enterprise-level systems, and delivering end-to-end solutions in support of complex processes, the two organizations are well-positioned to deliver greater value to their healthcare and life sciences customers through their partnership by bringing RWE into the mainstream of evidence generation capabilities.

“The use of RWE to optimize clinical trial design and to conduct observational studies as a way to identify new approaches to treatment has been increasing. Thanks to a growing acceptance of RWE by regulatory agencies, RWD has also been gaining traction as a source of supplemental evidence in the regulatory submissions,” said Basia Coulter, Global R&D Director at Globant. “We’re very excited to include the Dexter platform in our offerings for healthcare and life sciences customers.”

“We are delighted to be partnering with Globant. Their unique interdisciplinary technical expertise in both medical and data science, and their global reach, complements our software’s deep capability in RWE analyses,” said Dan Somers, CEO at Dexter. “This means that together we can create solutions and services for life sciences and healthcare providers all over the world, solving the many challenges they face such as speeding up clinical trials, improving outcomes, and improving the economics of healthcare and outcomes using rapid, data-driven, and transparent approaches.” 

To learn more about Globant’s Healthcare & Life Sciences Studio, please click here. 

---------------------------------

About Globant
We are a digitally native company that helps organizations reinvent themselves and unleash their potential. We are the place where innovation, design and engineering meet scale. 

• We have more than 26,500 employees and we are present in more than 20 countries working for companies like Google, Electronic Arts and Santander, among others.
• We were named a Worldwide Leader in CX Improvement Services by IDC MarketScape report.
• We were also featured as a business case study at Harvard, MIT, and Stanford.  
• We are a member of The Green Software Foundation (GSF) and the Cybersecurity Tech Accord.

Sign up to get first dibs on press news and updates. 
For more information, visit www.globant.com.
For media information contact pr@globant.com  

About Dexter 
Dexter is a provider of a software platform created by researchers and clinicians at the University of Birmingham, U.K.  It encompasses many years of academic research into ‘knowledge engineering’ that enables automatic transformation of heterogeneous real-world data (RWD), such as from primary health care or insurance data into data usable for analyses and generation of actionable insights and results, or real-world evidence (RWE).

About the University of Birmingham 
The University of Birmingham is ranked amongst the world’s top 100 institutions. Its work brings people from across the world to Birmingham, including researchers, teachers and more than 6,500 international students from over 150 countries.
University of Birmingham Enterprise helps students and researchers turn their ideas into new services, products and enterprises that meet real-world needs. We also support innovators and entrepreneurs with mentoring, advice, and training and manage the University’s Academic Consultancy Service. View our portfolio of technologies available for licensing.